A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Clinical trial NCT04244253 · COMPLETED

Trial details

NCT number: NCT04244253
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2020-03-03
Primary completion: 2022-02-08
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.